BR112015014243A8 - composição de vacina para uso em populações imunocomprometidas e uso da mesma - Google Patents
composição de vacina para uso em populações imunocomprometidas e uso da mesma Download PDFInfo
- Publication number
- BR112015014243A8 BR112015014243A8 BR112015014243A BR112015014243A BR112015014243A8 BR 112015014243 A8 BR112015014243 A8 BR 112015014243A8 BR 112015014243 A BR112015014243 A BR 112015014243A BR 112015014243 A BR112015014243 A BR 112015014243A BR 112015014243 A8 BR112015014243 A8 BR 112015014243A8
- Authority
- BR
- Brazil
- Prior art keywords
- vaccine
- immunocompromised populations
- vaccine composition
- immunocompromised
- populations
- Prior art date
Links
- 229960005486 vaccine Drugs 0.000 title abstract 5
- 239000000203 mixture Substances 0.000 title abstract 4
- 206010061598 Immunodeficiency Diseases 0.000 title abstract 3
- 241000700605 Viruses Species 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 230000001932 seasonal effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/543—Mucosal route intranasal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55588—Adjuvants of undefined constitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Pulmonology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Otolaryngology (AREA)
Abstract
resumo patente de invenção: "composição de vacina para uso em populações imunocomprometidas". a invenção se refere a composições de vacina intranasalmente administradas efetivas contra infecção em populações imunocomprometidas. um aspecto da invenção é direcionado ao uso pediátrico da vacina da invenção incluindo uma vacina efetiva em crianças contra estirpes de vírus da grupe sazonal. um aspecto adicional da invenção é direcionado a indivíduos de todos os grupos de idade quando a composição é para uso pandêmico.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP12197522.1A EP2742952A1 (en) | 2012-12-17 | 2012-12-17 | Influenza vaccine composition |
PCT/EP2013/077007 WO2014095944A1 (en) | 2012-12-17 | 2013-12-17 | Vaccine composition for use in immuno-compromised populations |
Publications (2)
Publication Number | Publication Date |
---|---|
BR112015014243A2 BR112015014243A2 (pt) | 2017-07-11 |
BR112015014243A8 true BR112015014243A8 (pt) | 2019-10-08 |
Family
ID=47358019
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112015014174A BR112015014174A2 (pt) | 2012-12-17 | 2013-12-17 | composição de vacina para indivíduos virgens |
BR112015014243A BR112015014243A8 (pt) | 2012-12-17 | 2013-12-17 | composição de vacina para uso em populações imunocomprometidas e uso da mesma |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112015014174A BR112015014174A2 (pt) | 2012-12-17 | 2013-12-17 | composição de vacina para indivíduos virgens |
Country Status (12)
Country | Link |
---|---|
US (2) | US11065325B2 (pt) |
EP (4) | EP2742952A1 (pt) |
JP (3) | JP2016502996A (pt) |
KR (3) | KR20150132093A (pt) |
CN (3) | CN104870010A (pt) |
AU (2) | AU2013360889C1 (pt) |
BR (2) | BR112015014174A2 (pt) |
CA (2) | CA2895023A1 (pt) |
HK (2) | HK1212611A1 (pt) |
MX (2) | MX2015007753A (pt) |
RU (2) | RU2661407C2 (pt) |
WO (2) | WO2014095944A1 (pt) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ607792A (en) * | 2010-09-30 | 2015-08-28 | Eurocine Vaccines Ab | Improved vaccine compositions |
KR20170063750A (ko) | 2014-09-26 | 2017-06-08 | 세퀴러스 유케이 리미티드 | 면역손상된 대상체의 백신 접종 |
ES2927797T3 (es) * | 2014-09-26 | 2022-11-11 | Seqirus Uk Ltd | Vacunación de sujetos inmunocomprometidos |
RU2634247C2 (ru) * | 2015-09-28 | 2017-10-24 | Федеральное государственное бюджетное научное учреждение "СЕВЕРО-КАВКАЗСКИЙ ЗОНАЛЬНЫЙ НАУЧНО-ИССЛЕДОВАТЕЛЬСКИЙ ВЕТЕРИНАРНЫЙ ИНСТИТУТ" (ФГБНУ СКЗНИВИ) | Способ стимуляции иммунного ответа и препарат для его осуществления |
US20200306364A1 (en) * | 2017-11-30 | 2020-10-01 | Ohio State Innovation Foundation | Mucoadhesive nanoparticle entrapped influenza virus vaccine delivery system |
WO2021209368A1 (en) * | 2020-04-16 | 2021-10-21 | Bayer Aktiengesellschaft | Active compound combinations and fungicide compositions comprising those |
BR112022020704A2 (pt) * | 2020-04-16 | 2022-11-29 | Bayer Ag | Combinações de compostos ativos e composições fungicidas compreendendo os mesmos |
CN115515426A (zh) * | 2020-04-16 | 2022-12-23 | 拜耳公司 | 活性化合物组合以及包含它们的杀真菌剂组合物 |
CN112063699B (zh) * | 2020-09-16 | 2021-06-18 | 成都市疾病预防控制中心 | 一种用于研究hiv感染者免疫衰老机制的系统 |
WO2023133342A2 (en) * | 2022-01-10 | 2023-07-13 | The Children's Medical Center Corporation | Methods and compositions relating to immunization of immune distinct patients |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9602280D0 (sv) | 1996-06-10 | 1996-06-10 | Pharmatrix Ab | Immunstimulerande lipidformulering |
SE9900496D0 (sv) | 1999-02-12 | 1999-02-12 | Pharmatrix Ab | Vaccine formulation |
US8410248B2 (en) | 1999-03-12 | 2013-04-02 | Human Genome Sciences Inc. | HWBAO62 polypeptides |
US20030072764A1 (en) | 2001-04-05 | 2003-04-17 | O'hagan Derek | Mucosal boosting following parenteral priming |
US20050208602A1 (en) | 2001-08-10 | 2005-09-22 | Rosen Craig A | 89 human secreted proteins |
AU2003301843A1 (en) | 2002-05-17 | 2004-06-07 | Human Genome Sciences, Inc. | 157 human secreted proteins |
SI1567191T1 (sl) | 2002-11-26 | 2011-01-31 | Eurocine Vaccines Ab | Novi adjuvans na aminski osnovi |
WO2005014038A1 (ja) | 2003-08-11 | 2005-02-17 | The Research Foundation For Microbial Diseases Of Osaka University | 粘膜免疫誘導アジュバントを含む新規ワクチン |
WO2006125076A2 (en) | 2005-05-18 | 2006-11-23 | Trinity Biosystems, Inc. | Methods and compositions for immunizing against chlamydia infection |
JP5214446B2 (ja) | 2005-06-30 | 2013-06-19 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 免疫アジュバントの調製のための化合物 |
JP5028627B2 (ja) | 2005-08-05 | 2012-09-19 | 国立大学法人徳島大学 | IgA抗体の選択的産生からIgA及びIgG両抗体産生への切換えを可能にする抗原薬物ビークルとこれを用いる経鼻・粘膜ワクチン |
RU2323742C1 (ru) * | 2007-02-15 | 2008-05-10 | Государственное учреждение Научно-исследовательский институт вакцин и сывороток им. И.И. Мечникова (ГУ НИИВС им. И.И. Мечникова) | Способ повышения иммуногенности инактивированной гриппозной вакцины |
US8668904B2 (en) | 2007-12-06 | 2014-03-11 | Glaxosmithkline Biologicals S.A. | Influenza composition |
WO2010033274A2 (en) | 2008-05-23 | 2010-03-25 | The Regents Of The University Of Michigan | Nanoemulsion adjuvants |
WO2009143524A2 (en) | 2008-05-23 | 2009-11-26 | The Regents Of The University Of Michigan | Nanoemulsion vaccines |
US20130178383A1 (en) | 2008-11-12 | 2013-07-11 | David Spetzler | Vesicle isolation methods |
ES2618576T3 (es) | 2009-05-28 | 2017-06-21 | Curna, Inc. | Tratamiento de enfermedades relacionadas con un gen antivírico mediante la inhibición de una transcripción antisentido natural a un gen antivírico |
NZ607792A (en) | 2010-09-30 | 2015-08-28 | Eurocine Vaccines Ab | Improved vaccine compositions |
-
2012
- 2012-12-17 EP EP12197522.1A patent/EP2742952A1/en not_active Withdrawn
-
2013
- 2013-12-17 AU AU2013360889A patent/AU2013360889C1/en not_active Ceased
- 2013-12-17 MX MX2015007753A patent/MX2015007753A/es unknown
- 2013-12-17 CN CN201380065877.2A patent/CN104870010A/zh active Pending
- 2013-12-17 RU RU2015129028A patent/RU2661407C2/ru not_active IP Right Cessation
- 2013-12-17 KR KR1020157019562A patent/KR20150132093A/ko not_active Application Discontinuation
- 2013-12-17 JP JP2015547077A patent/JP2016502996A/ja active Pending
- 2013-12-17 WO PCT/EP2013/077007 patent/WO2014095944A1/en active Application Filing
- 2013-12-17 AU AU2013360890A patent/AU2013360890B2/en not_active Ceased
- 2013-12-17 JP JP2015547078A patent/JP2016502997A/ja active Pending
- 2013-12-17 CN CN202110039199.9A patent/CN112826929A/zh active Pending
- 2013-12-17 MX MX2015007688A patent/MX2015007688A/es unknown
- 2013-12-17 CA CA2895023A patent/CA2895023A1/en not_active Abandoned
- 2013-12-17 EP EP18193418.3A patent/EP3431101A1/en not_active Withdrawn
- 2013-12-17 US US14/650,809 patent/US11065325B2/en active Active
- 2013-12-17 RU RU2015129077A patent/RU2661408C2/ru not_active IP Right Cessation
- 2013-12-17 EP EP13811462.4A patent/EP2931308B1/en not_active Not-in-force
- 2013-12-17 BR BR112015014174A patent/BR112015014174A2/pt not_active Application Discontinuation
- 2013-12-17 WO PCT/EP2013/077006 patent/WO2014095943A1/en active Application Filing
- 2013-12-17 KR KR1020217000812A patent/KR20210007042A/ko not_active Application Discontinuation
- 2013-12-17 US US14/650,807 patent/US20150306204A1/en not_active Abandoned
- 2013-12-17 KR KR1020157019558A patent/KR20150132092A/ko active Application Filing
- 2013-12-17 EP EP13805935.7A patent/EP2931307B1/en not_active Not-in-force
- 2013-12-17 CA CA2895028A patent/CA2895028A1/en not_active Abandoned
- 2013-12-17 CN CN201380065856.0A patent/CN104884085A/zh active Pending
- 2013-12-17 BR BR112015014243A patent/BR112015014243A8/pt not_active Application Discontinuation
-
2016
- 2016-01-20 HK HK16100580.8A patent/HK1212611A1/zh unknown
- 2016-02-14 HK HK16101591.3A patent/HK1213492A1/zh unknown
-
2019
- 2019-03-18 JP JP2019049330A patent/JP2019112448A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112015014243A8 (pt) | composição de vacina para uso em populações imunocomprometidas e uso da mesma | |
CL2017001191A1 (es) | Compuestos derivados de carbamoilpiridona policíclicos; composición farmacéutica que los comprende; y su uso para el tratamiento de una infección de vih en un humano que tiene o se encuentra en riesgo de tener la infección. | |
BR112014016810A2 (pt) | composições e métodos para tratamento de distúrbios metabólicos | |
BR112015011447A2 (pt) | composto da fórmula i, composição farmacêutica e de vacina, e, uso de um composto | |
BR112014011162A2 (pt) | derivados purínicos para o tratamento de infecções virais | |
BR112012020839A2 (pt) | vacinas para uso na profilaxe e tratamento de doença de vírus da influenza | |
UA114086C2 (xx) | Імуногенна композиція глікопротеїну g вірусу hendra і/або nipah | |
BR112015007366A2 (pt) | derivados de acilaminopirimidina para o tratamento de infecções virais e outras doenças | |
BR112015013695A2 (pt) | composição farmacêutica, e, métodos para tratamento e para prevenção de uma infecção por hiv | |
BR112015011439A2 (pt) | composto, composição farmacêutica, composição de vacina, e, uso de um composto | |
BR112015001313A2 (pt) | composições de vacina | |
CL2016002276A1 (es) | Composiciones tópicas que comprenden un extracto de coriolus versicolor para aumentar la autoinmunidad | |
AR083361A1 (es) | Forma de dosificacion de rapida disolucion de vacuna oral utilizando almidon | |
BR112014018815A8 (pt) | Composição imunogênica compreendendo conjugado proteína-polissacarídeo x de n. meningitidis | |
BR102013003570A8 (pt) | Composições de plasma rico em plaquetas | |
BR112015017966A2 (pt) | composições imunogênicas compreendendo vírus silificado e métodos de uso | |
CO6761399A2 (es) | Composiciones y métodos de vacuna del virus tipo 1b de diarrea viral bovina | |
BR112013018642A2 (pt) | vacinas e composições contra streptococcus pneumoniae | |
BRPI0918806A2 (pt) | composição compreendendo quitosana para administração ocular de vaninas em aves | |
BR112012029304A2 (pt) | copolíme-ros em bloco de polissiloxano e seu uso em formulações cosmeticas | |
BR112017022755A2 (pt) | formulações de glucopiranosil lipídeo a e alérgeno a amendoim para administração sublingual | |
BR112015031226A2 (pt) | Composição de vacina, e, uso da composição de vacina | |
BR112015002549A2 (pt) | regime de vacinação para proteger uma criança contra infecção ou doença causada por vírus sincicial respiratório, composição imunogênica ou pluralidade de composições imunogênicas, uso de uma composição imunogênica ou de uma pluralidade de composições imunogênicas | |
BR112015018200A2 (pt) | composição mastigável para administração oral e processo para preparar a mesma | |
BR112013023354A2 (pt) | vacina para rinite equina |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B06I | Publication of requirement cancelled [chapter 6.9 patent gazette] |
Free format text: ANULADA A PUBLICACAO CODIGO 6.6.1 NA RPI NO 2462 DE 13/03/2018 POR TER SIDO INDEVIDA. |
|
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B11B | Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements |